UPDATED May 05, 2024
Companies below a US$500M market cap with strong earnings growth forecasted for the next 3 years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
WAYS | kr23.50 | 1.3% | -54.8% | kr189.6m | kr39.75 | PS1.7x | E81.8% | 0% | Tech | ||
KEBNI B | kr1.50 | -7.4% | 39.3% | kr407.3m | kr1.80 | PS4.5x | E98.1% | n/a | Tech | ||
NEWBRY | kr3.23 | -5.3% | -41.9% | kr78.4m | kr8.00 | PS3.4x | E112.9% | n/a | Pharmaceuticals & Biotech | ||
CINIS | kr35.15 | 6.7% | -18.3% | kr2.5b | kr75.00 | PB6.3x | E77.3% | n/a | Materials | ||
CHECK | kr36.90 | -3.7% | -17.4% | kr1.1b | kr62.00 | PE312x | E70.0% | n/a | Software | ||
ENRAD | kr7.95 | 1.3% | 57.4% | kr194.1m | kr8.10 | PS25x | E55.5% | n/a | Capital Goods | ||
TFBANK | kr208.00 | -1.0% | 52.5% | kr4.5b | kr217.67 | PB2x | E26.4% | n/a | Banks | ||
CLBIO | kr10.45 | -0.9% | -35.7% | kr224.6m | kr29.00 | PS7.3x | E114.8% | n/a | Pharmaceuticals & Biotech | ||
DIGN | kr1.60 | 0.3% | -60.7% | kr112.8m | kr8.60 | PS1.3x | E139.0% | n/a | Healthcare | ||
YIELD | kr3.51 | -2.5% | -57.1% | kr188.0m | kr12.00 | PS1.1x | E88.5% | n/a | Diversified Financials | ||
EQL | kr44.80 | 3.5% | 30.2% | kr1.3b | kr48.00 | PE58.8x | E47.4% | n/a | Healthcare | ||
SKOLON | kr23.30 | -0.4% | -19.7% | kr618.5m | kr27.50 | PE90.8x | E67.4% | 2.4% | Software | ||
XBRANE | kr0.20 | -2.9% | -99.8% | kr309.0m | n/a | PS1.3x | E93.7% | n/a | Pharmaceuticals & Biotech | ||
DVYSR | kr100.00 | -2.0% | 15.7% | kr1.6b | kr126.01 | PS9.6x | E101.6% | n/a | Pharmaceuticals & Biotech | ||
SPAGO | kr0.34 | -5.3% | -53.3% | kr76.6m | n/a | PS12.9x | E52.1% | n/a | Pharmaceuticals & Biotech | ||
CTT | kr327.00 | -3.5% | 53.5% | kr4.1b | n/a | PE40.2x | E21.6% | 1.6% | Capital Goods | ||
HEXI | kr0.60 | -0.8% | -33.7% | kr216.8m | n/a | PS35.8x | E118.5% | n/a | Capital Goods | ||
XMR | kr0.16 | 30.7% | -70.2% | kr16.5m | n/a | PB7.8x | E107.9% | n/a | Software | ||
SUN4 | kr7.08 | 1.1% | -43.1% | kr111.3m | kr29.00 | PE14.4x | E49.6% | n/a | Capital Goods | ||
EGTX | kr6.47 | 10.2% | -22.5% | kr1.9b | kr13.38 | PS30.1x | E92.7% | n/a | Pharmaceuticals & Biotech | ||
MAVEN | kr20.70 | 1.0% | 36.2% | kr1.1b | kr25.00 | PE27.5x | E44.7% | 0.5% | Tech | ||
INCOAX | kr2.29 | 1.8% | -1.7% | kr247.7m | kr3.04 | PS3.1x | E77.4% | n/a | Tech | ||
PAX | kr36.90 | -2.4% | 14.2% | kr701.6m | kr80.00 | PE85.2x | E63.3% | n/a | Healthcare | ||
CRAD B | kr37.80 | -2.3% | 16.0% | kr1.3b | kr58.00 | PE35.8x | E34.9% | n/a | Healthcare |